ROI-NJ

“Dual-spectrum AI significantly enhances security operations by distinguishing real threats from environmental noise, ensuring highly accurate detection and reliable alarms,” said Babak Shir, vice president of engineering at Princeton-based SightLogix. https://lnkd.in/eyEByV9V

Op-Ed | The House settlement may be transformative, but not so fast, my friend, writes Matthew I. W. Baker, Esq.

To celebrate the company’s 15th annual Month of Giving, Jersey Mike's Subs locations across the country are joining forces with more than 200 local charities. During March, customers have the option to round up their purchase to the nearest dollar or donate $1, $3, or $5 when placing their order. Charities include hospitals, youth organizations, food banks and more. At the first nationwide fundraiser in 2011, all of Jersey Mike’s 454 locations raised $600,000 for 66 charities. Since then, Jersey Mike’s annual Month of Giving has raised more than $113 million for hundreds of local charities.

CentralReach, a leader in autism and IDD care software for applied behavior analysis (ABA), multidisciplinary therapy, and special education with an office in Holmdel, announced that it has entered into a definitive agreement to be acquired by Roper Technologies Inc. a global software investor Insight Partners. Roper Technologies, a $60 billion public company headquartered in Sarasota, Fla., provides an autonomous operating model, allowing its businesses to continue operating independently while benefiting from Roper’s financial strength and strategic expertise. Roper chose to acquire CentralReach due to its talented team, industry-leading solutions, vital role in advancing care and outcomes for individuals with autism and IDD, and compelling business model.

Op-Ed | Nonprofit safety net hospital serves a special role in Bergen County and beyond, writes Deborah Visconi

Casio America, Inc. is undergoing a major strategic transformation aimed at modernizing operations, fostering innovation and positioning the company for long-term growth. As part of the shift, the company will relocate its headquarters to Jersey City, establish a new operations center in Rockaway Township, and open a distribution hub in Sparks, Nev. to enhance logistics and e-commerce capabilities. “This is a strategic investment in Casio’s future,” said Tom Kato, chairman and CEO of Casio America. https://lnkd.in/e-HgtUW8

SightLogix, a provider of intelligent outdoor security solutions, has introduced dual-spectrum artificial intelligence for its SightSensor product line, combining thermal and visible AI validation to improve real-time intrusion detection and minimize false alarms. The new technology, designed for critical infrastructure and commercial applications, uses visible and thermal AI false alarm filtering to correlate detections from both video streams in real time.

Momentum continues to build around large-scale investment in Newark, as BridgeInvest has secured a $60 million loan for Cosmo 440, a newly developed Class A multifamily tower in the city’s historic Weequahic neighborhood. The financing will support the 216-unit project through its final phase, covering construction completion, reserves, and lease-up efforts. Located at 440 Elizabeth Avenue, Cosmo 440 features 216 residential units, including 48 one-bedroom, 120 two-bedroom, and 48 three-bedroom apartments, spanning 192,765-rentable-square feet.

A recent economic impact study conducted by Lightcast, a leading international provider of labor market analytics, reveals the significant financial contribution of County College of Morris (CCM) to the local economy. According to the study, CCM generated $586.1 million in added income for Morris County in fiscal year 2022-23, supporting 5,977 jobs—equivalent to one out of every 75 jobs in the region.

In a move aimed at accelerating its path to commercialization, TEVOGEN BIO, a clinical-stage immunotherapy biotech company, has appointed health care industry veteran David E. Banko as global head of government affairs and patient access. The biotech firm, which specializes in AI-driven immunotherapy drug discovery, is positioning itself for growth in key therapeutic areas, including oncology, virology, neurology and rheumatology. Banko’s expertise in market access strategy, health policy and payer engagement will be critical as Tevogen advances its pipeline toward regulatory approval and market entry.